Sign in

    Dr. Jorge Santos da Silva

    Chief Executive Officer at MoonLake Immunotherapeutics
    Since April 2022
    Age
    47 years
    Education
    Holds a Ph.D. in Neuronal Cell Biology from the University of Turin, Italy, and a B.Sc. in Molecular Biology from the University of Glasgow, United Kingdom.
    Tenure
    Joined MLTX in April 2022 as Chief Executive Officer after co-founding MoonLake AG and serving as its CEO from July 2021 until the merger, following an extensive leadership role at McKinsey & Company from September 2007 to June 2021.

    Also at MoonLake Immunotherapeutics

    DKR
    Dr. Kristian Reich
    Chief Scientific Officer
    MB
    Matthias Bodenstedt
    Chief Financial Officer

    About

    Dr. Jorge Santos da Silva has built a strong foundation in the life sciences, earning a Ph.D. in Neuronal Cell Biology from the University of Turin and a B.Sc. in Molecular Biology from the University of Glasgow. He further enriched his expertise with a work placement in neurobiology at the European Molecular Biology Laboratory and served as a Postdoctoral Fellow at Cold Spring Harbor Laboratory.

    Professionally, he spent nearly 14 years at McKinsey & Company, from September 2007 to June 2021, where he rose to the position of Senior Partner and led practice groups in the Pharmaceutical & Medical Products, Biotech, and Biosimilars sectors. His role involved advising top biopharmaceutical and biotechnology companies on strategy and operations.

    At MLTX, he joined in April 2022 as the Chief Executive Officer after having co-founded MoonLake AG and managing it as CEO from July 2021 until its merger with MLTX. Under his leadership, MLTX has advanced its Nanobody® sonelokimab into multiple late-stage clinical trials, secured positive regulatory feedback, and ensured financial stability through a cash runway extending to the end of 2026.

    His career is marked by a blend of academic rigor and executive leadership, driving innovative strategies in the biopharmaceutical sector while maintaining a commitment to advancing therapeutic solutions for inflammatory diseases.

    $MLTX Performance Under Dr. Jorge Santos da Silva

    Past Roles

    OrganizationRoleDate RangeDetails
    MoonLake AG Chief Executive Officer July 2021 - April 2022 Co-founded the company and led it until the merger with MLTX
    McKinsey & Company, Inc. Senior Partner September 2007 - June 2021 Led the Pharmaceutical & Medical Products Practice, Biotech group, and Biosimilars group
    Cold Spring Harbor Laboratory Postdoctoral Fellow N/A [N/A]Held a postdoctoral research position
    European Molecular Biology Laboratory Work Placement in Neurobiology N/A [N/A]Participated in a neurobiology work placement

    External Roles

    OrganizationRoleDate RangeDetails
    School of Medicine at the Minho University Professor and Board Advisor N/A [N/A]Active position held outside of MLTX

    Fixed Compensation

    Data from  FY 2023
    Component NameAmountPayment ScheduleAdditional Details
    Salary$586,333 AnnualAnnual base salary converted from CHF using monthly exchange rates on the last day of each month in 2023
    All Other Compensation$22,063 AnnualIncludes contributions to MoonLake AG Swiss Pension Plan (50% of required pension contributions calculated as 15% of the annual base salary) and other unspecified benefits

    Performance Compensation

    Data from  FY 2023

    No information available on performance compensation for 2023